FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I) , where D is pyrrolidine, X is a radical selected from a group containing C=O, SO2, (C=O)-NH, CH2, O-(C=O), (C=O)-O, (C=S)-NH, Y is a radical selected from a group containing - (CH2)n-E-(CH2)m-L-(CH2)k, where E is O, k, m and n are separately and independently equal to 0, 1, 2 and 3, Z is an alkyl, where the alkyl is CH2 or CH2CH2, A is a radical selected from a group containing benzyl, substituted benzyl, phenyl, substituted phenyl, alkyl and substituted alkyl, cycloalkyl, heterocyclyl, aryl, alkyloxyalkyl, substituted alkyloxyalkyl, alkyloxyaryl, B is a radical of formula (II) , where R1 is selected from a group containing H, alkyl and substituted alkyl, cycloalkyl, R2 is selected from a group containing H, benzyl, substituted benzyl, phenyl, substituted phenyl, alkyl and substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, heteroaryl, cycloalkylalkyl, substituted cycloalkylalkyl, G is an amino group which is substituted by a heteroaryl or substituted heteroaryl, and where Q and L each independently denotes a radical selected from a group containing (C=O)-NH, NH, CH2, NH-(C=O)-NH, NH-(C=O), NH-SO2, NRc, (C=O)-NRc, and where Ra, Rb, Rc and Rd each independently denotes a radical selected from a group containing H, alkyl, cycloalkyl, heterocyclyl, aryl, substituted aryl, as well as to use of these compounds as integrin inhibitor and for making a medicinal and a diagnostic agent, to a pharmaceutical composition based on these compounds and to methods of treating integrin-associated condition.
EFFECT: novel compounds which are integrin inhibitors and can be used to treat diseases where angiogenesis inhibition is necessary are obtained and described.
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS, WHICH ARE ACTIVE TOWARDS RECEPTORS, ACTIVATED BY PEROXISOME PROLIFERATOR | 2004 |
|
RU2356889C2 |
DERIVATIVES OF BETA-ALANINE | 2000 |
|
RU2234496C2 |
DERIVATIVES OF CHROMENONE AND CHROMANONE AS INTEGRIN INHIBITORS | 1999 |
|
RU2234505C2 |
SUBSTITUTED ANILIDES, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT | 1998 |
|
RU2233269C2 |
DERIVATIVES OF QUINAZOLINE | 2003 |
|
RU2296757C2 |
PYRAZOLO[1,5-a]PYRIMIDINE AND THIENO[3,2-b]PYRIMIDINE DERIVATIVES AS MODULATORS OF IRAK-4 | 2011 |
|
RU2604062C2 |
TETRAHYDROCARBAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC AGENT THEREOF, METHOD OF TREATING AND/OR PREVENTING PHYSIOLOGICAL AND/OR PATHOLOGICAL CONDITIONS MEDIATED BY LHRH RECEPTOR BY ABOVE DERIVATIVES | 2008 |
|
RU2497806C9 |
SPIROIMIDAZOLIDINE DERIVATIVES, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2245879C2 |
ACETIC ACID DERIVATIVES | 1994 |
|
RU2151768C1 |
DERIVATIVES OF DOLASTATIN 10 | 2002 |
|
RU2296750C2 |
Authors
Dates
2010-06-27—Published
2005-03-24—Filed